Cencora (COR) Long-Term Investments (2013 - 2014)
Cencora's (COR) quarterly Long-Term Investments came in at $18.6 million in Q3 2014, up 12.53% YoY from $16.6 million in Q3 2013, and down 84.18% on a QoQ basis from $117.8 million in Q2 2014.
Cencora (COR) Long-Term Investments (2013 - 2014) Analysis & Trends
Cencora (COR) has 2 years of Long-Term Investments data on file, last reported at $18.6 million in Q3 2014.
- Quarterly Long-Term Investments rose 12.53% year-over-year to $18.6 million in Q3 2014, while the trailing twelve-month figure through Sep 2014 was $18.6 million (up 12.53% YoY) and the FY2014 annual result came in at $18.6 million, up 12.53% from the prior year.
- Long-Term Investments fell to $18.6 million in Q3 2014, from $117.8 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $117.8 million in Q2 2014 to a low of $16.6 million in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | - |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | - |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | - |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 604.00 Mn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | - |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | - |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | - |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | - |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 18.64 Mn |
| Jun 30, 2014 | 117.80 Mn |
| Sep 30, 2013 | 16.56 Mn |